Oriental Biotech: Developed high-quality Ebola antigen and nucleic acid testing reagents

Dongfang Biotechnology: High quality Ebola antigen and nucleic acid testing reagents have been developed. At the online performance briefing for the 2026 half year, Dongfang Biotechnology stated that the company has developed high-quality Ebola antigen and nucleic acid testing reagents, and has also laid out testing reagents for other vector borne diseases. The relevant market is expanding. In addition, the company's quantum dot flow fluorescent equipment and reagents have obtained multiple certificates at home and abroad, and have gradually been industrialized and entered the domestic and international markets, with good market feedback.